Izza Bazigh, MD
Rheumatology · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 11
- 2 carriers
- Office
- 1
- Since medical school
- 8 years
- Graduated 2018
Offices
1 location · Regents Univ of California UCSF · 276 clinicians in this group
Hospitals listed: Mayo Clinic Hospital. That is not proof they admit you there this week.
Plans that list them
11 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Bazigh’s office at (415) 476-1000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
11 of 11 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Mayo Clinic HospitalPhoenix, AZAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Mayo Clinic Health System, which runs 26 hospitals in 5 statesHome of Mayo Clinic Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 5 of 5 · 93% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — SSI - Colon Surgery: 1.616, Oct 2024 – Sep 2025Better than the national rate — Abdominopelvic accidental puncture or laceration rate: 0.36 (0 to 0.99) · 5,539 cases, Jul 2022 – Jun 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 115.44 (80.81 to 150.07) · 306 cases, Jul 2022 – Jun 2024Better than the national rate — Pressure ulcer rate: 0.21 (0 to 0.58) · 16,145 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.486, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.56, Oct 2024 – Sep 2025
See every measure and the patient survey for Mayo Clinic Hospital
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 1 better, 7 the same, 0 worse of 8 measures. Readmissions: 4 better, 7 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 1.616 | Worse | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.36 (0 to 0.99) · 5,539 cases | Better | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 115.44 (80.81 to 150.07) · 306 cases | Better | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.21 (0 to 0.58) · 16,145 cases | Better | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.486 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.56 | Better | Oct 2024 – Sep 2025 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.91 (0.75 to 1.08) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 96 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.2 · 144 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 8.3 · 271 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 7.7 · 884 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 11.2 · 1,245 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.9 · 274 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.3 · 5,311 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.06 to 0.38) · 17,299 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.19 (0.04 to 0.35) · 19,712 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.12 (2.86 to 5.38) · 6,130 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.24 (1.25 to 3.22) · 3,321 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 3.17 (2.23 to 4.11) · 5,145 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.11 (6.21 to 12) · 3,094 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.66 (3.86 to 7.47) · 3,309 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.85 (0.68 to 3.02) · 2,189 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 6.9 · 107 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.682 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.477 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.73 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.9 · 228 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.8 · 776 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -3.8 · 280 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -18.9 · 1,023 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -9 · 1,336 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 1,118 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.3 (4.5 to 8.8) · 469 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (7.2 to 12.7) · 469 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6 · 112 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.2 · 69 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 17.8 · 130 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 15.7 (12.7 to 19.3) · 2,211 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.9 to 1.2) · 3,441 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,947 patients answered, 35% of those asked)
| Cleanliness | 4 |
| Nurse communication | 5 |
| Doctor communication | 5 |
| Communication about medicines | 4 |
| Discharge information | 5 |
| Overall hospital rating | 5 |
| Quietness | 5 |
| Recommend hospital | 5 |
| Room was "always" clean | 80% |
| Nurses "always" communicated well | 88% |
| Doctors "always" communicated well | 86% |
| Staff "always" explained | 70% |
| Yes, staff "did" give patients this information | 93% |
| Yes, staff "did" give patients information about help after discharge | 93% |
| Doctors "always" explained things so they could understand | 81% |
| Doctors "always" listened carefully | 86% |
| Doctors "always" treated them with courtesy and respect | 92% |
| Patients who gave a rating of "9" or "10" (high) | 91% |
| Staff "always" explained new medications | 83% |
| Nurses "always" explained things so they could understand | 84% |
| Nurses "always" listened carefully | 86% |
| Nurses "always" treated them with courtesy and respect | 93% |
| "Always" quiet at night | 70% |
| "YES", patients would definitely recommend the hospital | 93% |
| Staff "always" explained possible side effects | 57% |
| Yes, staff "did" give patients information about possible symptoms | 93% |
Drugs they prescribed that Part D paid
$264,015
Pharmacies billed $264,015 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 168) in 2024. At or below the middle of the specialty; the typical internal medicine clinician is at 1%.
129 generic and 39 brand-name prescriptions · $264,015 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Colchicine | 12 | $885 | $74 |
| Prednisone | 51 | $692 | $14 |
| Methotrexate | 12 | $339 | $28 |
| Allopurinol | 14 | $135 | $10 |
Year by year
| 2024 | 168 | 29 | 0% (0) | 23% | $264,015 |
| 2023 | 109 | 49 | 0% (0) | 10% | $12,237 |
| 2022 | 147 | 89 | 0% (0) | 10% | $6,041 |
| 2021 | 78 | 36 | 0% (0) | None | $5,804 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2022: 1 drug
| Cefdinir | 11 | $121 | $11 |
Money from drug and device companies
$104 in 2022
| 2022 | 3 | 5 | None | $104 |
| 2021 | 1 | 1 | None | $15 |
| 2020 | 1 | 1 | None | $23 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Novo Nordisk | Ozempic | $65 | 3 payments
|
| Amgen | Evenity | $23 | 1 payment
|
| Medtronic | Linq II | $15 | 1 payment
|
See all 5 published payments
| Medtronic | Meals · 2022-12-19 | Linq II | $15 |
| Novo Nordisk | Meals · 2022-08-16 | Ozempic | $25 |
| Amgen | Meals · 2022-07-11 | Evenity | $23 |
| Novo Nordisk | Meals · 2022-05-26 | Rybelsus | $23 |
| Novo Nordisk | Meals · 2022-03-24 | Ozempic | $17 |
See earlier years (2021, 2020)
2021: $15
| Xeris Pharmaceuticals | Gvoke Pfs | $15 | 1 payment
|
2020: $23
| Novo Nordisk | Saxenda | $23 | 1 payment
|
Professional record
- NPI
- 1679196836
- Licence
- AZ 70252
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RR0500X (207RR0500X)
- Mailing address
- 13400 E Shea Blvd, Scottsdale, AZ, 85259
- NPI first listed
- 2020-05-22
- NPI last updated
- 2025-11-25
- NPI record certified
- 2025-11-25
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 11375 Cortez Boulevard, Sr 50, Office of Graduate Medic, Brooksville, FL, 34613 · 13400 E Shea Blvd, Scottsdale, AZ, 85259
This office lists an electronic records connection.